Structure−Activity Relationship Studies of a Series of Antiviral and Antibacterial Aglycon Derivatives of the Glycopeptide Antibiotics Vancomycin, Eremomycin, and Dechloroeremomycin
- 5 May 2005
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 48 (11) , 3885-3890
- https://doi.org/10.1021/jm0500774
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Patents on glycopeptides of the vancomycin family and their derivatives as antimicrobials: January 1999 – June 2003Expert Opinion on Therapeutic Patents, 2004
- Antiretroviral Activity of Semisynthetic Derivatives of Glycopeptide AntibioticsJournal of Medicinal Chemistry, 2003
- Role of the Glycopeptide Framework in the Antibacterial Activity of Hydrophobic Derivatives of Glycopeptide AntibioticsJournal of Medicinal Chemistry, 2003
- A novel soluble analog of the HIV-1 fusion cofactor, globotriaosylceramide (Gb3), eliminates the cholesterol requirement for high affinity gp120/Gb3 interactionJournal of Lipid Research, 2002
- Chlorobiphenyl-desleucyl-vancomycin inhibits the transglycosylation process required for peptidoglycan synthesis in bacteria in the absence of dipeptide bindingFEMS Microbiology Letters, 2000
- Regulation of Transcription by a Protein MethyltransferaseScience, 1999
- A Modification of the N-Terminal Amino Acid in me Eremomycin Aglycone.The Journal of Antibiotics, 1996
- Antibacterial activities and modes of action of vancomycin and related glycopeptidesAntimicrobial Agents and Chemotherapy, 1991
- 9-(2-phosphonylmethoxyethyl)adenine (PMEA) effectively inhibits retrovirus replication in vitro and simian immunodeficiency virus infection in rhesus monkeysAIDS, 1991
- Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDSScience, 1984